Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Vista Pharmaceuticals Ltd

Your Vote -

Buy

75.00%

Hold

0.00%

Sell

25.00%

75.00%

4 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Vista Pharmaceuticals Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Vista Pharmaceut - Clarification Regarding Date Mentioned In The Covering Letter For Notice Of Extraordinary General Meeting

    1 Mar 2025, 12:48PM Clarification Regarding Date Mentioned in covering letter for Notice of Extraordinary General Meetings (EGM)
  • Vista Pharmaceut - Notice Of Extra- Ordinary General Meeting Of The Company To Be Held On 20.03.2025

    25 Feb 2025, 4:12PM Notice of the Extra Ordinary General Meeting of the company to be held on 20.03.2025
  • Vista Pharmaceut - Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of SEBI (Listing Obligations And Di

    19 Feb 2025, 5:59PM Outcome of Board meeting under regulation 30 of SEBI (Listing obligation and disclosure requirement Regulation), 2015
  • Vista Pharmaceut - Board Meeting Intimation for Raising Of Funds By Way Of Issue Of Equity Or Convertible Warrants On Prefere

    14 Feb 2025, 1:46PM VISTA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/02/2025 ,inter alia, to consid
  • Vista Pharmaceut posts Q3 net loss of Rs 1.32 cr

    13 Feb 2025, 10:50AM The company reported standalone net loss during the quarter stood at Rs 1.32 crore as compared to net loss of Rs 1.63 crore in the previous year quart
  • Vista Pharmaceut - Integrated Filing (Financial)

    12 Feb 2025, 6:57PM Integrated Filling for the quarter ended 31.12.2024
  • Vista Pharmaceut - Results For The Quarter And Nine Months Ended 31.12.2024

    12 Feb 2025, 6:54PM Outcome of the Board meetings for Approval of Unaudited financial results for the quarter ended 31.12.2024
  • Vista Pharmaceut - Board Meeting Intimation for Un Audited Financials Results For The Quarter Ended 31.12.2024

    3 Feb 2025, 4:07PM VISTA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 ,inter alia, to consid
  • Vista Pharmaceut - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    20 Jan 2025, 1:20PM Compliance Certificate under reg 74 (5) of SEBI (DP) Regulations, 2018
  • Vista Pharmaceut has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2024

    20 Jan 2025, 1:10PM As of December 2024, 21.19% is owned by Promoters and 78.81% by Public. <p align=justify> Among Promoters holding, Indian Promoters holds 11.91% and F

Key fundamentals

Evaluate the intrinsic value of Vista Pharmaceuticals Ltd stock 

Name March-24 March-23 March-22 March-21 March-20
Assets 48.4271 46.6666 48.004 47.8226 45.1092
Liabilities 48.4271 46.6666 48.004 47.8226 45.1092
Equity 9.433 7.5113 7.3588 7.3588 6.0731
Gross Profit -3.5713 -4.4446 -1.2106 -1.7297 -4.7973
Net Profit -4.512 -5.662 -0.8319 -1.8852 -3.6772
Cash From Operating Activities -4.914 -1.7114 -0.993 -6.7466 0.8025
NPM(%) -43.85 -564.11 -210.82 -148.86 -16.15
Revenue 10.2878 1.0037 0.3946 1.2664 22.759
Expenses 13.8591 5.4483 1.6052 2.9961 27.5563
ROE(%) -11.23 -14.1 -2.07 -4.69 -9.15

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Vista Pharmaceuticals Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 809.25 -0.64 11.41 6.28 1321.50 1.42
Lotus Eye Hospital and Institute Ltd 58.19 1.50 237.75 22.88 14.01 0.88
Bharat Immunological and Biologicals Corporation Ltd 21.32 -1.30 0.00 47.50 -39.50 0.00
Astec Lifesciences Ltd 654.90 -5.39 0.00 21.57 -239.30 0.00

Company Info

Vista Pharmaceuticals Limited was incorporated on 25.01.1991 under the Companies Act of 1956 with the Registrar of Companies Andhra Pradesh and has obtained Certificate of Commencement of Business on 7th February 1991. Vista Pharmaceuticals was incorporated by Dr. Dhananjaya Alli and his associates. The capital was subscribed by Vista Pharmaceuticals Inc., an Overseas Corporate Body promoted by them as a per the laws of the State of New Jersy, United States of America. The company is setting up a 100% EOU for manufcacture of drug formulations with an installed capacity of 400 million tablets and 200 million capsules per annum. 2003 -To issue 352907 fully convertible warrants on preferential basis to Vista Pharmaceuticals Inc convertible into one equity share within a period of 18 months at a conversion price of Rs 10/- -Increase the Authorised capital from Rs 80 million to Rs 100 million.

Vista Pharmaceuticals Limited was incorporated on 25.01.1991 under the Companies Act of 1956 with the Registrar of Companies Andhra Pradesh and has obtained Certificate of Commencement of Business on 7th February 1991. Vista Pharmaceuticals was incorporated by Dr. Dhananjaya Alli and his associates. The capital was subscribed by Vista Pharmaceuticals Inc., an Overseas Corporate Body promoted by them as a per the laws of the State of New Jersy, United States of America. The company is setting up a 100% EOU for manufcacture of drug formulations with an installed capacity of 400 million tablets and 200 million capsules per annum. 2003 -To issue 352907 fully convertible warrants on preferential basis to Vista Pharmaceuticals Inc convertible into one equity share within a period of 18 months at a conversion price of Rs 10/- -Increase the Authorised capital from Rs 80 million to Rs 100 million.

Read More

Parent Organisation

Vista Pharmaceuticals Ltd.

Founded

25/01/1991

Managing Director

Mr.Murali Meraga

NSE Symbol

FAQ

The current price of Vista Pharmaceuticals Ltd is

The 52-week high for Vista Pharmaceuticals Ltd is

The market capitalization of Vista Pharmaceuticals Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Vista Pharmaceuticals Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Vista Pharmaceuticals Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Vista Pharmaceuticals Ltd shares.

The CEO of Vista Pharmaceuticals Ltd is Mr.Murali Meraga, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT